Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
A Standard patent application filed on 16 May 2008 credited to Weiberth, Franz Jr.
;
Shutske, Gregory
;
Gill, Harpa
;
Hemmerle, Horst
;
Hendrix, James A.
;
Jurcak, John G.
;
Zhao, Xu-Yang
;
Bordeau, Kenneth J.
;
Urmann, Matthias
;
Mueller, Paul J.
;
Jackson, Sharon A.
;
Details
Application number :
2008202190
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
Inventor :
Weiberth, Franz Jr.
;
Shutske, Gregory
;
Gill, Harpa
;
Hemmerle, Horst
;
Hendrix, James A.
;
Jurcak, John G.
;
Zhao, Xu-Yang
;
Bordeau, Kenneth J.
;
Urmann, Matthias
;
Mueller, Paul J.
;
Jackson, Sharon A.
;
Agent name :
Watermark Patent and Trade Marks Attorneys
Address for service :
Level 2 302 Burwood Road Hawthorn VIC 3122 Australia
Filing date :
16 May 2008
Associated companies :
Applicant name :
Aventis Pharmaceuticals Inc
Applicant address :
55 Corporate Drive Bridgewater NJ 08807 United States of America